Peer-reviewed articleOpen access

Psychedelic-Assisted Psychotherapy After COVID-19: The Therapeutic Uses of Psilocybin and MDMA for Pandemic-Related Mental Health Problems.

Argento E, Christie D, Mackay L iD, Callon C, Walsh Z

Frontiers in psychiatrySep 6, 2021License: open accessCanada8 citationsDOI: 10.3389/fpsyt.2021.716593

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

PsilocybinMDMAPTSD

Keywords

TraumaMental healthPsychedelicsPsychedelic-assisted PsychotherapyCovid-19 Pandemic

View paper Full text (PDF)

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.

Related research

ArticlePsilocybin

Australia to prescribe MDMA and psilocybin for PTSD and depression in world first.

Haridy R

Europe PMC2023

ArticlePsilocybin

Psychedelics and Mental Health in Endurance Athletes: A Cross-Sectional Study in Brazil.

Portes MAM, Bertoglio LJ

Europe PMC2026

ArticlePsilocybin

The helioscope effect: A new framework for evaluating trauma-related memory processing in psychedelic experiences.

Diehl VJ, Calder AE, Hasler G

Europe PMC2026